Back to Companies
Voyager Therapeutics, Inc.
VYGRNasdaqCIK: 0001640266
Voyager Therapeutics, Inc. (VYGR) shows 23 recent insider filings from 15 insiders, with all of them on the sell side. With $0 in purchases and $281.1K in sales, the recent tape is heavily weighted toward selling (net sales of $281.1K). Ferguson Toby (Chief Medical Officer) is the most active by dollar volume, and the single largest transaction was $772.8K by Swartz Robin. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$3.7M
Purchases
$0
Sales
$281.1K
Unique Insiders
15
Recent Insider Trades
23 loaded
| Jun 11 | VYGR Voyager Therapeutics, Inc. | Onyia Jude | Director | Award | $102.9K |
| Jun 11 | VYGR Voyager Therapeutics, Inc. | SCANGOS GEORGE A | Director | Award | $102.9K |
| Jun 11 | VYGR Voyager Therapeutics, Inc. | PIERCE GLENN | Director | Award | $102.9K |
| Jun 11 | VYGR Voyager Therapeutics, Inc. | Vitale Nancy | Director | Award | $102.9K |
| Jun 11 | VYGR Voyager Therapeutics, Inc. | GERAGHTY JAMES A | Director | Award | $102.9K |
| Jun 11 | VYGR Voyager Therapeutics, Inc. | Higgins Michael J | Director | Award | $102.9K |
| Jun 11 | VYGR Voyager Therapeutics, Inc. | Colon Grace | Director | Award | $102.9K |
| Jun 11 | VYGR Voyager Therapeutics, Inc. | MACKEY CATHERINE J | Director | Award | $102.9K |
| Jun 11 | VYGR Voyager Therapeutics, Inc. | Hyman Steven | Director | Award | $102.9K |
| Apr 3 | VYGR Voyager Therapeutics, Inc. | Sandrock Alfred | President and CEO, Director | Sell | $44.5K |
| Apr 3 | VYGR Voyager Therapeutics, Inc. | Shiferman Gregory L. | SVP and General Counsel | Grant | $0 |
| Feb 26 | VYGR Voyager Therapeutics, Inc. | Swartz Robin | COO & CBO | Sell | $24.3K |
| Feb 26 | VYGR Voyager Therapeutics, Inc. | Jorgensen Nathan D. | Chief Financial Officer | Sell | $17.6K |
| Feb 26 | VYGR Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Sell | $15.7K |
| Feb 26 | VYGR Voyager Therapeutics, Inc. | Sandrock Alfred | President and CEO, Director | Sell | $53.8K |
| Feb 11 | VYGR Voyager Therapeutics, Inc. | Swartz Robin | COO & CBO | Sell | $17.6K |
| Feb 10 | VYGR Voyager Therapeutics, Inc. | Swartz Robin | COO & CBO | Grant | $772.8K |
| Feb 10 | VYGR Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Grant | $566.7K |
| Feb 10 | VYGR Voyager Therapeutics, Inc. | Ferguson Toby | Chief Medical Officer | Grant | $772.8K |
| Jan 8 | VYGR Voyager Therapeutics, Inc. | Shiferman Gregory L. | SVP and General Counsel | Other | $0 |
| Jan 8 | VYGR Voyager Therapeutics, Inc. | Shiferman Gregory L. | SVP and General Counsel | Award | $402.0K |
| Oct 7 | VYGR Voyager Therapeutics, Inc. | Jorgensen Nathan D. | Chief Financial Officer | Sell | $36.6K |
| Aug 20 | VYGR Voyager Therapeutics, Inc. | Ferguson Toby | Chief Medical Officer | Sell | $70.9K |
23 filings